DAVID CHAPLIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-11-12 David Chaplin(1) 595,600 *
2011-02-18 David Chaplin(1)
2012-11-19 David Chaplin(1) 6,655 * Mr. Chaplin's employment with the company ended on August 30, 2011.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22